Quarterly ResultMay 6, 2026, 04:07 PM
LifeMD Q1 Revenue $50.2M; Gross Margin 88%; Affirms FY26 Guidance
AI Summary
LifeMD, Inc. reported strong first-quarter 2026 financial results, with revenue of $50.2 million, surpassing its guidance. The company achieved a significant gross margin expansion to 88% and recorded its largest quarterly net addition of over 42,000 telehealth subscribers, bringing the total to over 365,000. Key growth areas like GLP-1 weight management and Women’s Health saw substantial patient sign-up increases. LifeMD exited the quarter with a healthy cash balance of $34.5 million and no debt, while affirming its full-year 2026 financial guidance.
Key Highlights
- Q1 2026 revenue was $50.2 million, exceeding company guidance of $48 million to $49 million.
- Adjusted EBITDA loss for Q1 2026 was $4.5 million, in line with company guidance.
- Gross margin increased by 420 basis points to 88% compared to Q1 2025.
- Active telehealth subscribers grew 26% year-over-year to over 365,000, with 42,000 net adds in Q1.
- GLP-1 weight management new-patient revenues grew approximately 120% versus Q4 2025.
- Women’s Health patient sign-ups increased 657% quarter-over-quarter.
- The company exited the quarter with $34.5 million in cash and no debt.
- LifeMD affirmed full-year 2026 guidance for revenue of $220 million to $230 million and adjusted EBITDA of $12 million to $17 million.